MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on March 27, 2007; DOI: 10.1124/mol.107.034561


0026-895X/07/7106-1457-1462$20.00
Mol Pharmacol 71:1457-1462, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.034561v1
71/6/1457    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Penolazzi, L.
Right arrow Articles by Piva, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Penolazzi, L.
Right arrow Articles by Piva, R.
Accelerated Communication

Induction of Estrogen Receptor {alpha} Expression with Decoy Oligonucleotide Targeted to NFATc1 Binding Sites in Osteoblasts

Letizia Penolazzi, Margherita Zennaro, Elisabetta Lambertini, Elisa Tavanti, Elena Torreggiani, Roberto Gambari, and Roberta Piva

Department of Biochemistry and Molecular Biology, Molecular Biology Section, Ferrara University, Ferrara, Italy

The nuclear factor of activated T cell cytoplasmic 1 (NFATc1) is a member of the NFAT family and is strictly implicated in the growth and development of bone. Most studies have focused on the effects of NFATc1 activation on osteoclastogenesis. On the contrary, the specific roles of NFAT in osteoblast differentiation are not well understood and, in some instances, reports of its role are contradictory. In the present study, we demonstrated that NFATc1 was involved in the transcriptional regulation of human estrogen receptor {alpha} (ER{alpha}) gene in SaOS-2 osteoblastic like cells. NFATc1 was specifically recruited "in vivo" at C and F distal promoters of ER{alpha} gene. In addition, it is here identified as the negative transcription factor removed by the RA4-3'decoy oligonucleotide able to induce ER{alpha} expression in osteoblasts. Ca2+/calcineurin-NFAT-mediated signaling pathways and ER{alpha}-dependent signals are involved in diverse cellular reactions by regulating gene expression under both physiological and pathological conditions. Therefore, our data might be useful for proper manipulation of NFATc1- and ER{alpha}-mediated cellular reactions in different bone disorders, such as osteoporosis.


Received January 29, 2007; accepted March 27, 2007

Address correspondence to: Roberta Piva, Department of Biochemistry and Molecular Biology, Molecular Biology Section, Via Fossato di Mortara, 74, 44100 Ferrara, Italy. E-mail: piv{at}unife.it







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics